Medical Communications

New ADUHELM (aducanumab-avwa) Phase III data has shown a positive correlation between plasma p-tau reduction and less cognitive and functional …

Researchers have found that blood pressure drugs may directly reduce people’s risk of type 2 diabetes, a condition that an …

A trial has been launched to evaluate how to increase COVID-19 vaccine protection among vulnerable patients taking immunosuppressant drugs . …

Kintor Pharma, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the company has dosed the …

BIAL have announced the appointment of Jorg Holenz as R&D General Manager, replacing Patricio da Silva, who steps down after …

The FDA has declined to grant Emergency Use Authorisation for NRx Pharmaceuticals’ therapy, Zyesami® (aviptadil), in the treatment of critical …

Pfizer UK and Entia’s home blood monitoring device for breast cancer patients is in late-stage development, with regulatory approvals expected …

Republican governors are expected to sue in response to the Biden administration’s requirement that US employers ensure workers are tested …

A new study has shown that combining two existing cancer drugs for leukaemia and melanoma could offer a promising future …

HMNC Brain Health, a clinical-stage biopharma company pioneering the development of personalised therapies powered by predictive companion diagnostics, today announced …

The pandemic has undoubtedly had a detrimental impact on the pharmaceutical and healthcare industries. Brexit has rubbed salt in the …

Pharmaceutical manufacturers have always been tasked with some of the most complex remits in the industry. Active pharmaceutical ingredients, potent …

Amphista Therapeutics have appointed Beverley Carr Chief Business Officer. Amphista is a leader in next generation targeted protein degradation (TPD) …

Mogrify Limited have announced the appointment of Tom Graney, CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. He …

Gilead Sciences announced that it has entered into a clinical trial collaboration and supply agreement with MSD (known as Merck …